World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
9765
World Ranking
4145
National Ranking
62

Geert Raes publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Geert Raes sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 184 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Geert Raes D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Geert Raes sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Geert Raes is affiliated with Vrije Universiteit Brussel in Belgium. Their research primarily spans medicine and immunology and microbiology, with 44 publications in medicine and 26 in immunology and microbiology. Their work delves deeper into subfields such as immunology, radiology, nuclear medicine and imaging, oncology, molecular biology, and reproductive medicine.

The scientist's research topics focus on areas including monoclonal and polyclonal antibodies research, immunotherapy and immune responses, CAR-T cell therapy research, immune cells in cancer, cancer immunotherapy and biomarkers, radiopharmaceutical chemistry and applications, and glycosylation and glycoproteins research.

Geert Raes has authored multiple papers in various scientific journals. Some of the recent publications include:

  • Systemic Reprogramming of Monocytes in Cancer (2020) published in Frontiers in Oncology
  • Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients (2020) published in Journal of Nuclear Medicine
  • IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D (2020) published in Cancer Immunology Research
  • Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation (2020) published in Biomolecules
  • Applications of nanobodies in brain diseases (2022) published in Frontiers in Immunology

The scientist frequently publishes in venues such as Frontiers in Immunology, Journal of Nuclear Medicine, European Journal of Immunology, Pharmaceuticals, and Frontiers in Oncology. They have contributed extensively to Frontiers in Immunology with six publications and Journal of Nuclear Medicine with three publications.

Frequent collaborators of Geert Raes include Nick Devoogdt, Jo A. Van Ginderachter, Marleen Keyaerts, Máté Kiss, and Damya Laoui. Collaboration counts range from seven to eighteen joint publications with these coauthors, reflecting ongoing partnerships in scientific research.

Best Publications

  • Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells

    Charlotte L Scott;Fang Zheng;Fang Zheng;Patrick De Baetselier;Liesbet Martens

  • Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

    Chiara Porta;Monica Rimoldi;Geert Raes;Lea Brys

  • Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages

    Geert Raes;Patrick De Baetselier;Wim Noël;Alain Beschin

  • Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion.

    Jo A. Van Ginderachter;Kiavash Movahedi;Gholamreza Hassanzadeh Ghassabeh;Sofie Meerschaut

  • Alternatively activated macrophages during parasite infections.

    Wim Noël;Geert Raes;Gholamreza Hassanzadeh Ghassabeh;Patrick De Baetselier

  • Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells.

    Geert Raes;Rafaël Van den Bergh;Patrick De Baetselier;Gholamreza Hassanzadeh Ghassabeh

  • Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages

    Kiavash Movahedi;Steve Schoonooghe;Damya Laoui;Isabelle Houbracken

  • Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation.

    Geert Raes;Lea Brys;Bhola K. Dahal;Jef Brandt

  • Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression

    Damya Laoui;Eva Van Overmeire;Patrick De Baetselier;Jo A. Van Ginderachter

  • Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions.

    Gholamreza Hassanzadeh Ghassabeh;Patrick De Baetselier;Patrick De Baetselier;Lea Brys;Lea Brys;Wim Noël;Wim Noël

  • Reactive Oxygen Species and 12/15-Lipoxygenase Contribute to the Antiproliferative Capacity of Alternatively Activated Myeloid Cells Elicited during Helminth Infection

    Lea Brys;Alain Beschin;Geert Raes;Gholamreza Hassanzadeh Ghassabeh

  • FIZZ1 and Ym as Tools to Discriminate between Differentially Activated Macrophages

    Geert Raes;Wim Noël;Alain Beschin;Lea Brys

  • 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

    Matthias D'Huyvetter;Jens De Vos;Catarina Xavier;Marek Pruszynski

  • Myeloid-derived suppressor cells in parasitic infections.

    Jo A. Van Ginderachter;Alain Beschin;Patrick De Baetselier;Geert Raes

  • PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments

    Anneleen Blykers;Steve Schoonooghe;Catarina Xavier;Kevin D’hoe

  • In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT

    Ilse Vaneycken;Jochen Govaert;Cécile Vincke;Vicky Caveliers

  • Expression of the Inhibitory CD200 Receptor Is Associated with Alternative Macrophage Activation

    Nathalie Koning;Marco van Eijk;Walter Pouwels;Michael S.M. Brouwer

  • Alternatively Activated Myeloid Cells Limit Pathogenicity Associated with African Trypanosomiasis through the IL-10 Inducible Gene Selenoprotein P

    Tom Bosschaerts;Martin Guilliams;Wim Noel;Michel Hérin

  • Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types

    Kurt De Groeve;Nick Deschacht;Celine De Koninck;Vicky Caveliers

  • Heterogeneity of macrophage activation in fish.

    Maria Forlenza;Inge R. Fink;Geert Raes;Geert F. Wiegertjes

  • Theranostics in immuno-oncology using nanobody derivatives

    Quentin Lecocq;Yannick De Vlaeminck;Heleen Hanssens;Matthias D'Huyvetter

  • Transcriptome analysis of monocyte-HIV interactions

    Rafael Van den Bergh;Eric Florence;Erika Vlieghe;Tom Boonefaes

Frequent Co-Authors

Patrick De Baetselier
Patrick De Baetselier Vrije Universiteit Brussel
Jo A. Van Ginderachter
Jo A. Van Ginderachter Vrije Universiteit Brussel
Karine Breckpot
Karine Breckpot Vrije Universiteit Brussel
Alain Beschin
Alain Beschin Vrije Universiteit Brussel
Serge Muyldermans
Serge Muyldermans Vrije Universiteit Brussel
Frank Brombacher
Frank Brombacher University of Cape Town
Stefan Magez
Stefan Magez Ghent University
Carlo Heirman
Carlo Heirman Vrije Universiteit Brussel
Kris Thielemans
Kris Thielemans Vrije Universiteit Brussel
Richard Bucala
Richard Bucala Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced nursing roles and specialized healthcare careers. Many professionals look to expand their expertise through targeted programs such as acnp programs, which prepare family nurse practitioners to work in acute care settings. These programs focus on critical care skills essential for managing seriously ill patients.

For those who are new to nursing or considering a career shift, online ABSN programs for non nurses provide an accelerated path to becoming a registered nurse. These programs are designed to equip individuals without a nursing background with the skills and knowledge required for clinical practice.

After obtaining a nursing degree, professionals often pursue specialties with higher earning potential. Research highlights the highest paid DNP specialties, guiding students toward areas that combine passion with financial reward. Additionally, students may consider accelerated NP programs, which expedite the journey toward becoming a nurse practitioner in various specialties.

Combining immunology knowledge with these flexible online pathways helps healthcare professionals advance their careers, meet growing industry demands, and contribute to critical patient care outcomes.

Best Scientists Citing Geert Raes

Trending Scientists

Recently Published Articles